Publications by authors named "M Rizk-Rabin"

Claim this Profile
T
Tumor suppressor gene ARMC5 controls adrenal redox state through NRF1 turnover.
Isadora P Cavalcante, Marthe Rizk-Rabin, Christopher Ribes, Karine Perlemoine, Constanze Hantel

Endocr Relat Cancer· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic classification of benign adrenocortical lesions.
Simon Faillot, Thomas Foulonneau, Mario Néou, Stéphanie Espiard, Simon Garinet, Marthe Rizk-Rabin

Endocr Relat Cancer· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cullin 3 targets the tumor suppressor gene ARMC5 for ubiquitination and degradation.
Isadora Pontes Cavalcante, Anna Vaczlavik, Ludivine Drougat, Claudimara Ferini Pacicco Lotfi, Karine Perlemoine, Marthe Rizk-Rabin

Endocr Relat Cancer· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Link between steroidogenesis, the cell cycle, and PKA in adrenocortical tumor cells.
Marthe Rizk-Rabin, Sabrina Chaoui-Ibadioune, Anna Vaczlavik, Christopher Ribes, Michel Polak

Mol Cell Endocrinol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MET overexpression and activation favors invasiveness in a model of anaplastic thyroid cancer.
Cyril Garcia, Camille Buffet, Laila El Khattabi, Marthe Rizk-Rabin, Karine Perlemoine

Oncotarget· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis